BioSpace News Archive

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced that it will present at two upcoming investor conferences in September:

G1 Therapeutics, Inc., a clinical-stage oncology company, announced that the company will participate in the following investor conferences in September 2020:

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that Adam Grossman, President and Chief Executive Officer, is scheduled to participate in the following upcoming investor conferences in September

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations.

Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced that members of its management team will participate in three upcoming virtual investor conferences.

With best-in-class team and targeted investment initiatives, Company optimally positioned to increase market share in highly valued hemostat market

In case of injury, trauma, or defect in the lower extremities of the body, i.e. the feet and ankles, special plates and screws are available for use to rectify and reconstruct them.

The growing prevalence of cervical cancer is propelling the global cervical cancer endoscopic devices market.

Transparency Market Research has published a new report titled, “Radiation Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Intraoral scanners are the digital devices used to capture 3-dimentional image of the internal area of the mouth.